Which statement must appear on the label for Schedule II-V medications according to federal requirements?

Which statement must appear on the label for Schedule II-V medications according to federal requirements?

• A. “CAUTION: Federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed.”
• B. Pharmacy name and address
• C. Date of filling
• D. The directions for use

Answer: (A)

Federal labeling for Schedule II–V controlled substances requires a transfer prohibition notice on the label. This warning—stating that federal law prohibits transferring the drug to anyone other than the patient for whom it was prescribed—comes from the Controlled Substances Act and DEA regulations to prevent unauthorized distribution and ensure the medication is used only by the intended patient. While other information like the pharmacy name and address, date filled, and directions for use are common on prescription labels, the transfer prohibition is the specific federally required line for these medications.

Federal labeling for Schedule II–V controlled substances requires a transfer prohibition notice on the label. This warning—stating that federal law prohibits transferring the drug to anyone other than the patient for whom it was prescribed—comes from the Controlled Substances Act and DEA regulations to prevent unauthorized distribution and ensure the medication is used only by the intended patient. While other information like the pharmacy name and address, date filled, and directions for use are common on prescription labels, the transfer prohibition is the specific federally required line for these medications.